J. H. Fuller

3.8k total citations · 2 hit papers
29 papers, 2.9k citations indexed

About

J. H. Fuller is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, J. H. Fuller has authored 29 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Epidemiology. Recurrent topics in J. H. Fuller's work include Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Diet and metabolism studies (5 papers) and Diabetes Management and Research (5 papers). J. H. Fuller is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Diet and metabolism studies (5 papers) and Diabetes Management and Research (5 papers). J. H. Fuller collaborates with scholars based in United Kingdom, United States and Germany. J. H. Fuller's co-authors include H. Keen, R. J. Jarrett, Lynda Stevens, N. J. Morrish, M Shipley, G Rose, F. A. Miles, Margaret McCartney, R. J. Jarrett and W. R. S. North and has published in prestigious journals such as Science, The Lancet and Diabetes.

In The Last Decade

J. H. Fuller

29 papers receiving 2.8k citations

Hit Papers

Mortality and causes of d... 1983 2026 1997 2011 2001 1983 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
J. H. Fuller 1.7k 783 466 439 421 29 2.9k
Jan Cederholm 1.9k 1.1× 738 0.9× 516 1.1× 450 1.0× 378 0.9× 76 2.9k
Masanori Iwase 965 0.6× 540 0.7× 395 0.8× 642 1.5× 383 0.9× 110 2.6k
Giancarlo Tonolo 974 0.6× 1.0k 1.3× 501 1.1× 539 1.2× 202 0.5× 107 3.2k
Giuseppe Seghieri 1.3k 0.8× 490 0.6× 560 1.2× 618 1.4× 276 0.7× 115 3.3k
J. H. Fuller 2.0k 1.2× 1.1k 1.4× 368 0.8× 683 1.6× 466 1.1× 58 4.0k
Franco Cavalot 2.1k 1.3× 1.2k 1.5× 701 1.5× 594 1.4× 540 1.3× 118 4.2k
R.J. Heine 845 0.5× 516 0.7× 539 1.2× 516 1.2× 299 0.7× 43 2.8k
Roberto Torella 1.1k 0.6× 522 0.7× 637 1.4× 633 1.4× 1.0k 2.4× 135 3.1k
Camila Manrique 1.0k 0.6× 1.1k 1.4× 522 1.1× 447 1.0× 372 0.9× 55 2.7k
Shoichiro Nagasaka 932 0.6× 603 0.8× 540 1.2× 588 1.3× 702 1.7× 112 2.8k

Countries citing papers authored by J. H. Fuller

Since Specialization
Citations

This map shows the geographic impact of J. H. Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. H. Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. H. Fuller more than expected).

Fields of papers citing papers by J. H. Fuller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. H. Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. H. Fuller. The network helps show where J. H. Fuller may publish in the future.

Co-authorship network of co-authors of J. H. Fuller

This figure shows the co-authorship network connecting the top 25 collaborators of J. H. Fuller. A scholar is included among the top collaborators of J. H. Fuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. H. Fuller. J. H. Fuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schoenaker, Danielle, Gita D. Mishra, M. Toeller, et al.. (2015). Association of diet and lifestyle with glycated haemoglobin in type 1 diabetes participants in the EURODIAB prospective complications study. European Journal of Clinical Nutrition. 70(2). 229–236. 18 indexed citations
2.
Keen, H., et al.. (2013). The Concomitants of Raised Blood Sugar: Studies in Newly-Detected Hyperglycaemics. International Journal of Epidemiology. 43(1). 11–15. 13 indexed citations
3.
Fuller, J. H., et al.. (2005). Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus (Withdrawn Paper) 1997, art. no. CD002188). UCL Discovery (University College London). 6 indexed citations
4.
Lee, E. T., et al.. (2001). Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity. Diabetologia. 44(S2). S3–S13. 92 indexed citations
5.
Bennett, P. H., et al.. (2001). Increased urinary albumin excretion and its associations in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 44(S2). S37–S45. 29 indexed citations
6.
Colhoun, Helen M., E. T. Lee, Minjie Lu, et al.. (2001). Risk factors for renal failure: The WHO multinational study of vascular disease in diabetes. Diabetologia. 44(S2). S46–S53. 71 indexed citations
7.
Morrish, N. J., et al.. (2001). Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 44(S2). S14–S21. 950 indexed citations breakdown →
8.
Chaturvedi, Nish, J. H. Fuller, Marja‐Riitta Taskinen, et al.. (2001). The EURODIAB Prospective Complications Study Group. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. 24(12). 2071–2077. 24 indexed citations
9.
Karamanos, B., Massimo Porta, Marco Songini, et al.. (2000). Different risk factors of microangiopathy in patients with Type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study. Diabetologia. 43(3). 348–355. 45 indexed citations
10.
Colhoun, Helen M., et al.. (2000). Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients. Diabetologia. 43(11). 1353–1359. 21 indexed citations
11.
Toeller, M., Anette E. Buyken, G. Heitkamp, et al.. (1999). Fiber intake, serum cholesterol levels, and cardiovascular disease in European individuals with type 1 diabetes. EURODIAB IDDM Complications Study Group.. PubMed. 22 Suppl 2. B21–8. 30 indexed citations
12.
Fuller, J. H., M Shipley, G Rose, R. J. Jarrett, & H. Keen. (1983). Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.. BMJ. 287(6396). 867–870. 510 indexed citations breakdown →
13.
West, Kelly M, M. M. S. Ahuja, P. H. Bennett, et al.. (1982). Interrelationships of microangiopathy, plasma glucose and other risk factors in 3583 diabetic patients: A multinational study. Diabetologia. 22(6). 412–420. 57 indexed citations
14.
Fuller, J. H., et al.. (1980). Coronary Heart Disease Risk Factors and Socio-Economic Status in a London Population. Clinical Science. 59(3). 29P–29P. 1 indexed citations
15.
Fuller, J. H., H. Keen, R. J. Jarrett, et al.. (1979). Haemostatic variables associated with diabetes and its complications.. BMJ. 2(6196). 964–966. 234 indexed citations
16.
Jarrett, R. J., H. Keen, J. H. Fuller, & Margaret McCartney. (1979). Worsening to diabetes in men with impaired glucose tolerance (?borderline diabetes?). Diabetologia. 16(1). 25–30. 150 indexed citations
17.
Fuller, J. H., et al.. (1978). Plasma lipids in a London population and their relation to other risk factors for coronary heart disease.. Heart. 40(2). 170–176. 19 indexed citations
18.
Jarrett, R. J., H. Keen, J. H. Fuller, & Margaret McCartney. (1977). Treatment of borderline diabetes: controlled trial using carbohydrate restriction and phenformin.. BMJ. 2(6091). 861–865. 30 indexed citations
19.
Miles, F. A. & J. H. Fuller. (1975). Visual Tracking and the Primate Flocculus. Science. 189(4207). 1000–1002. 168 indexed citations
20.
Keen, H., R. J. Jarrett, & J. H. Fuller. (1975). ORAL HYPOGLYCÆMICS IN DIABETES MELLITUS. The Lancet. 306(7940). 865–866. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026